Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fmicb.2026.1760954.s002BackgroundDiabetic kidney disease (DKD) is one of the leading causes of end-stage kidney disease worldwide, and microbiota-based interventions are considered potential preventive and therapeutic strategies to slow its progression. This study evaluated the efficacy of probiotic supplementation in patients with DKD through a systematic review and meta-analysis.MethodsWe searched seven databases, including PubMed, Embase, the Cochrane Library (CENTRAL), CNKI, Wanfang, VIP and SinoMed, to identify all relevant studies published from database inception to July 2025. Eligible studies were randomized controlled trials assessing probiotic interventions in DKD patients. Study quality was evaluated using the Cochrane Risk of Bias tool, and meta-analyses were performed using R.ResultsA total of 11 studies involving 726 participants were included. Probiotic supplementation significantly improved serum creatinine (MD − 0.17, −0.22 to −0.12, p ConclusionProbiotic supplementation may improve metabolic disturbances, renal function, and systemic inflammation/oxidative stress in DKD patients. However, its clinical efficacy and long-term effects require further validation in large-scale studies.
Keyword(s):
complementary therapy; diabetic kidney disease; meta-analysis; Microbiology; probiotics.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)